After receiving a prostate cancer assessment, men and their loved ones want the diagnosis to be accurate, personalized, and promptly delivered.
Today, we are privileged to welcome Joseph Mossel as our distinguished guest. He is joining us to bring you up to date on artificial intelligence and explain how it is utilized in the battle against prostate cancer.
Joseph currently serves as the CEO and Co-founder of Ibex Medical Analytics. Alongside Co-founder and Chief Technology Officer, Chaim Linhart, he embarked on a journey to empower pathologists with the invaluable insights of AI to enhance their diagnostic accuracy, efficiency, and turnaround times for cancer diagnoses.
Joseph has a Master of Science in Computer Science from Tel Aviv University and a Master of Science in Environmental Science from VU Amsterdam. With a career spanning over two decades, his professional journey began in software development and product management, leading him to take on leadership roles in startups and large multinational corporations. He has expertly guided various products from inception to maturity in the tech industry. He has also contributed to the nonprofit sector, serving as the Managing Director of the National Ecosystem Assessment Program in Israel.
Join us today to learn about the innovative solutions and cutting-edge advancements at the intersection between technology and healthcare that Joseph and Ibex Medical Analytics have brought to the forefront of prostate cancer diagnosis.
Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation.
Show highlights:
- How Joseph started Ibex about seven years ago
- What does Ibex focus on?
- How digital pathology can improve the accuracy and objectivity of cancer diagnoses
- How digital pathology can reduce healthcare costs
- How the Ibex AI solution impacts urology
- What should urologists and patients understand about AI technology?
- How does Ibex impact health economics?
- How the Ibex technology benefits those with an early-stage cancer diagnosis
- How AI-based pathology tools for prostate cancer are already in use by 100 labs worldwide
Joseph’s remarkable journey reflects his deep commitment to innovation in technology for healthcare. He and his Ibex team are trailblazers in digital pathology, which empowers pathologists with AI-driven insights to revolutionize their diagnostic accuracy, efficiency, and turnaround times.
Thank you for joining us today for a glimpse into the future of prostate cancer diagnosis, where cutting-edge advancements and innovative solutions are reshaping the landscape of medical care!
Be sure to tune in for more enlightening discussions in future episodes!
Links:
Connect with Dr. Pohlman
Follow Dr. Pohlman on Twitter and Instagram – @gpohlmanmd
Get your free What To Expect Guide (or find the link on our podcast website)
Join our Facebook group
Follow Dr. Pohlman on Twitter and Instagram
Go to the Prostate Health Academy to sign up.
You can access Dr. Pohlman’s free mini webinar, where he discusses his top three tips to promote men’s prostate health, longevity, and quality of life here.
Connect with Ibex Medical and Joseph
Ibex Medical Analytics on YouTube
Ibex Medical Analytics on LinkedIn
Joseph Mossel on LinkedInLink to the Lancet article
Recent Comments